# A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers

> **NCT01970072** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 79 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Remimazolam Tosylate
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01970072
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-14
- **Primary completion:** 2014-06-20
- **Final completion:** 2014-06-20
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970072, "A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01970072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*